Study Stopped
Slow enrollment
RAMP Study: A Study Comparing Two Lumbar Fusion Procedures
RAMP
RAMP Study: A Prospective Randomized Study Comparing Two Lumbar Fusion Procedures
1 other identifier
observational
200
1 country
11
Brief Summary
This is a post-marketing, on-label Efficacy, Effectiveness and Safety Study designed in a Multicenter, Randomized, Prospective format. This study compares two spinal fusion procedures, Transacral Interbody Fusion and Transforaminal Lumbar Interbody Fusion (TLIF). Enrollment period will be approximately 12-18 months; each Principal Investigator/Study Center will be expected to enroll up to 20 subjects. The protocol requires approximately 7 subject visits to the study center from screening through the final follow-up visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
Typical duration for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 24, 2012
CompletedFirst Posted
Study publicly available on registry
October 29, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedJuly 9, 2014
July 1, 2014
2.1 years
October 24, 2012
July 8, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy
Efficacy: Fusion of the targeted vertebral bodies (L4-L5-S1 or L5-S1) will be assessed individually at 24 months as determined by Central Radiographic Reviewer's (orthopedic surgeon) interpretation of high resolution Computed Tomography (CT) Scan.
24 months post-operative
Study Arms (2)
transacral lumbar interbody fusion procedure
transforaminal lumbar interbody fusion procedure (TLIF)
Eligibility Criteria
To be eligible to participate in this study, the subject must meet all of the inclusion criteria and none of the exclusion criteria.
You may qualify if:
- Male or female subject that is eligible for both study procedures only at the L4-L5-S1 or L5-S1 levels with bilateral pedicle screws;
- The subject has a diagnosis of one or more of the following conditions at the L4-L5-S1 or L5-S1 levels:
- Spinal stenosis;
- Spondylolisthesis;
- Degenerative Disc Disease (DDD) defined as back pain and/or radicular pain with degeneration of the disc as confirmed by history, physical examination and radiographic studies, either by CT, MRI, plain film, myelography, or discography;
- Adult 18 years of age or older;
- The subject has undergone at least 6 consecutive months of Conservative Care Therapy(ies);
- The subject is able and willing to give written informed consent and to comply with the requirements of this study protocol.
You may not qualify if:
- Coagulopathy;
- Bowel disease (e.g. Crohn's, ulcerative colitis);
- Severe scoliosis (curves \> 60°);
- Sacral agenesis;
- Spondylolisthesis greater than Grade 1 at the L4-L5-S1 levels, or greater than Grade 2 at the L5-S1 level;
- Spinal tumor (or history of sacral tumor);
- History of fracture at L4, L5 and/or S1 vertebral bodies;
- The subject has undergone a prior fusion procedure of the lumbar spine;
- Osteoporosis; or, if the subject is at high risk for development of osteoporosis, further screening to be conducted at Investigator's discretion;
- For women of childbearing potential, pregnancy at the time of enrollment, or planning to become pregnant during the course of the study;
- The subject has a history of substance abuse (illegal drugs, prescription drugs, or alcohol) that, in the Investigator's opinion, may interfere with protocol assessments and/or the subject's ability to comply with the protocol;
- Per the Investigator, the subject is in poor general health or undergoing any concurrent disease process that would place the subject in excessive risk to surgery (e.g. significant circulatory problems, cardiac disease, history of bowel surgery);
- The subject is participating in another spine study, which, in the opinion of the Investigator, could skew results;
- The subject is involved in litigation related to their back condition;
- The subject is contraindicated to receive either study procedure;
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
St. Joseph Heritage Healthcare
Fullerton, California, 92835, United States
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Indiana Spine Group
Carmel, Indiana, 46032, United States
Bone and Joint Clinic of Baton Rouge
Baton Rouge, Louisiana, 70808, United States
LSU Health Sciences Center, Department of Neurosurgery
New Orleans, Louisiana, 70112, United States
UMass Medical Center, Department of Neurosurgery
Worcester, Massachusetts, 01655, United States
Cary Orthopaedic Spine Specialists
Cary, North Carolina, 27518, United States
Mayfield Clinic/University of Cincinnati
Cincinnati, Ohio, 45219, United States
University Hospitals Case Medical Center
Cleveland, Ohio, 44106, United States
Brazos Spine
College Station, Texas, 77845, United States
Danville Orthopedic Clinic, Inc.
Danville, Virginia, 24541, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Hart, MD
University Hospitals Cleveland Medical Center
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2012
First Posted
October 29, 2012
Study Start
June 1, 2012
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
July 9, 2014
Record last verified: 2014-07